Pacific Biosciences Of California (PACB) Return on Capital Employed Growth (3y) (2014 - 2026)
Pacific Biosciences Of California (PACB) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 370.00 |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | 132.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.00 |
| Mar 31, 2026 | 193.00 |
| Dec 31, 2025 | -5,676.00 |
| Sep 30, 2025 | -7,250.00 |
| Jun 30, 2025 | -7,460.00 |
| Mar 31, 2025 | -7,151.00 |
| Dec 31, 2024 | -1,966.00 |
| Jun 30, 2024 | -1,835.00 |
| Mar 31, 2024 | -667.00 |
| Dec 31, 2023 | 1,339.00 |
| Sep 30, 2023 | 5,782.00 |
| Jun 30, 2023 | 8,918.00 |
| Mar 31, 2023 | 15,311.00 |
| Dec 31, 2022 | 8,263.00 |
| Sep 30, 2022 | 8,907.00 |
| Jun 30, 2022 | 7,177.00 |
| Mar 31, 2022 | 6,951.00 |
| Dec 31, 2021 | 5,032.00 |
| Jun 30, 2021 | 6,046.00 |
| Mar 31, 2021 | 5,884.00 |